Stabilized pharmaceutical compositions comprising substantially monomeric interferon-beta and methods useful in their preparation are provided. The use of these compositions in the treatment of eye, respiratory and ear conditions is also disclosed. Furthermore, a manufacturing method for such a microfluidic component is described. Another method and system are also provided for managing a security threat in a distributed system.